Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue SUPPL. 1, 1998, Pages

  Fazekas, Franz ^a   Barkhof, Frederik ^b   Filippi, Massimo ^c  

^a UNIVERSITY OF GRAZ   (Austria)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Contrast enhancement; Diagnosis; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

CONFERENCE PAPER; CONTRAST ENHANCEMENT; CORPUS CALLOSUM; DIAGNOSTIC ACCURACY; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

BRAIN; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS;

EID: 0031778902     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (50)

1. Allen IV, Kirk J. Demyelinating diseases. In: Adams JH, Duchen LW, eds. Greenfield's neuropathology. 5th ed. London: Edward Arnold, 1992:447-520.
2. Jacobs L, Simon HJ. Neuroimaging of multiple sclerosis and related disorders. In: Greenberg JO, ed. Neuroimaging: a companion to Adams and Victor's principles of neurology. New York: McGraw-Hill, 1995:479-502.
3. Goodkin DE, Rudick RA, Ross JS. The use of brain magnetic resonance imaging in multiple sclerosis. Arch Neurol 1994;51:505-16.
4. Fazekas F, Offenbacher H, Hartung HP. What is the role of ancillary investigations in establishing the diagnosis of multiple sclerosis? Eur Neurol 1997;38:255-7.
5. Fazekas F, Schmidt R, Offenbacher H, et al. Prevalence of white matter and periventricular magnetic resonance hyperintensities in asymptomatic volunteers. J Neuroimaging 1991;1:27-30.
6. Horowitz AL, Kaplan RD, Grewe G, et al. The ovoid lesion: a new MR observation in patients with multiple sclerosis. AJNR Am J Neuroradiol 1989;10:303-5.
7. Uhlenbrock D, Sehlen S. The value of T1-weighted images in the differentiation between MS, white matter lesions, and subcortical arteriosclerotic encephalopathy (SAE). Neuroradiology 1989;3:203-12.
8. Truyen L, van Waesberghe JHTM, van Walderveen MAA, et al. Accumulation of hypointense lesions (black holes) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-76.
9. van Walderveen M, Scheltens PH, van Waesberghe JH, et al. Histopathologic correlate of hypointense lesions on T1-weighted SE MR images in multiple sclerosis. Neurology 1997;48:A361.
10. Brainin M, Reisner T, Neuhold A, et al. Topological characteristics of brainstem lesions in clinically definite and clinically probable cases of multiple sclerosis: an MRI study. Neuroradiology 1987;29:530-4.
11. Offenbacher H, Fazekas F, Schmidt R, et al. Assessment of MRI criteria for a diagnosis of MS. Neurology 1993;43: 905-9.
12. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997;120:2059-69.
13. Revesz T, Kidd D, Thompson AJ, et al. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994;117:759-65.
14. Filippi M, Yousry T, Baratti C, et al. Quantitative assessment of MRI lesion load in multiple sclerosis. A comparison of conventional spin-echo with fast fluid-attenuated inversion recovery. Brain 1996;119:1349-55.
15. Stevenson VL, Gawne-Cain ML, Barker GJ, et al. Imaging of the spinal cord and brain in multiple sclerosis: a comparative study between fast FLAIR and fast spin echo. J Neurol 1997;244:119-24.
16. Boggild MD, Williams R, Haq N, et al. Cortical plaques visualised by fluid-attenuated inversion recovery imaging in relapsing multiple sclerosis. Neuroradiol 1996;38 (suppl 1):S10-3.
17. Simon JH, Holtas SL, Schiffer RB, et al. Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis detection with MR. Radiology 1986;160:363-7.
18. Gean-Marton AD, Vezina LG, Marton KI, et al. Abnormal corpus callosum: a sensitive and specific indicator of multiple sclerosis. Radiology 1991;180:215-21.
19. Offenbacher H, Poltrum B, Strasser-Fuchs S, et al. The contribution of corpus callosum lesions to the MRI diagnosis of multiple sclerosis. Eur J Neurol 1996;3 (suppl 4):2-3.
20. Hashemi RH, Bradley WG, Chen DY, et al. Suspected multiple sclerosis: MR imaging with a thin-section fast FLAIR pulse sequence. Radiology 1995;196:505-10.
21. Paty DW, Oger JJF, Kastrukoff LF, et al. Magnetic resonance imaging in the diagnosis of multiple sclerosis (MS): a prospective study of comparison with clinical evaluation, evoked potential, oligoclonal banding, and CT. Neurology 1988;38:180-5.
22. Fazekas F, Offenbacher H, Fuchs S, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988;38:1822-5.
23. Katz D, Taubenberger JK, Cannella B, et al. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol 1993;34:661-9.
24. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
25. Thompson AJ, Miller D, Youl B, et al. Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-3.
26. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39: 6-16.
27. Tas MW, Barkhof F, van Walderveen MAA, et al. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis. AJNR Am J Neuroradiol 1995;16:259-64.
28. Smith ME, Stone LA, Albert PS, et al. Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol 1993;33: 480-9.
29. Koudriavtseva T, Thompson AJ, Fiorelli M, et al. Gadolinium enhanced MRI predicts clinical and MRI disease activity in relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;62:285-7.
30. Filippi M, Yousry T, Campi A, et al. Comparison of triple dose versus standard dose gadolinium-DTPA for the detection of MRI enhancing lesions in patients with MS. Neurology 1996;46:379-84.
31. Filippi M, Capra R, Campi A, et al. Triple dose of Gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:526-30.
32. Mehta RC, Pike GB, Enzmann DR. Improved detection of enhancing and non-enhancing lesions of multiple sclerosis with magnetization transfer. AJNR Am J Neuroradiol 1995;16:1771-8.
33. van Waesberghe JHTM, Castelijns JA, Roser W, et al. Single dose gadolinium with MT versus triple dose gadolinium in the MR detection of MS lesions. AJNR Am J Neuroradiol 1997;18:1279-85.
34. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-7.
35. Hittmair K, Mallek R, Prayer D, et al. Spinal cord lesions in patients with multiple sclerosis: comparison of MR pulse sequences. AJNR Am J Neuroradiol 1996;17:1555-65.
36. Thorpe JW, MacManus DG, Kendall BE, et al. Short tau inversion recovery fast spin echo (fast STIR) imaging of the spinal cord in multiple sclerosis. Magn Reson Imaging 1994;12:983-9.
37. Filippi M, Yousry TA, Alkadhi H, et al. Spinal cord MRI in multiple sclerosis with multicoil arrays: a comparison between fast spin echo and fast FLAIR. J Neurol Neurosurg Psychiatry 1996;61:632-5.
38. Fazekas F. Diseases of the spinal cord. In: Greenberg JO, ed. Neuroimaging: a companion to Adams and Victor's principles of neurology. New York: McGraw-Hill, 1995: 459-78.
39. Thorpe JW, Kidd D, Miller DH, et al. Spinal cord MRI using multi-array coils and fast spin-echo. I. Findings in normal controls. Neurology 1993;43:2625-31.
40. Tartaglino LM, Friedman DP, Flanders AE, et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 1995;195:725-32.
41. Campi A, Filippi M, Comi G, et al. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up. AJNR Am J Neuroradiol 1995;16:115-23.
42. Papadopoulos A, Gouliamos A, Trakadas S, et al. MRI in the investigation of patients with myelopathy thought to be due to multiple sclerosis. Neuroradiology 1995;37: 384-7.
43. Thorpe JW, Kidd D, Moseley IF, et al. Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996;119:709-14.
44. Thorpe JW, Kidd D, Moseley IF, et al. Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 1996; 46:372-8.
45. Miller DH, Newton MR, van der Poel JC, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988;38:175-9.
46. Simon J, Szumowski J, Totterman S, et al. Fat suppression MRI of the orbit. AJNR Am J Neuroradiol 1988;9:961-8.
47. Miller DH, MacManus DG, Bartlett PA, et al. Detection of optic nerve lesions in optic neuritis using frequency selective fat saturation sequences. Neuroradiology 1993; 35:156-8.
48. Gass A, Moseley IF, Barker GJ, et al. Lesion discrimination in optic neuritis using high-resolution fat-suppressed fast spin-echo MRI. Neuroradiology 1996;38: 317-21.
49. Gass A, Barker GJ, MacManus D, et al. High resolution magnetic resonance imaging of the anterior visual pathway in patients with optic neuropathies using fast spin echo and phased array local coils. J Neurol Neurosurg Psychiatry 1995;58:562-9.
50. Barkhof F. The role of magnetic resonance imaging in diagnosis of multiple sclerosis In: Thompson AJ, Polman CH, Hohlfeld R, eds. Multiple sclerosis: clinical challenges and controversies. London: Martin Dunitz publishers, 1997(in press).